On 2026-10-08, Cantor Fitzgerald raised its PFE price target to $28.
Cantor Fitzgerald 于 2026-10-08 将 PFE 目标价上调至 $28。
For information only. Not investment advice.内容仅供参考，不构成投资建议。
PFE receives FDA approval for as Front-Line Maintenance TreatmentPfizer Inc.（PFE）的 as Front-Line Maintenance Treatment 获美国 FDA 批准
Material Company Event · October 7, 2026公司公告 · 2026/10/7
Scotiabank raises PFE target to $33 from $30Scotiabank 上调目标价 辉瑞 (PFE)：$30 → $33
Rating Change · October 6, 2026评级变动 · 2026/10/6
HSBC raises PFE target to $30 from $28HSBC 上调目标价 辉瑞 (PFE)：$28 → $30
Rating Change · September 10, 2026评级变动 · 2026/9/10
